NCT06821945

A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

A Multi-Center, Randomized, Double-Blind, Parallel-Design, Exploratory Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizophrenia

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Boryung Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

The objective of this clinical trial is to evaluate the safety and efficacy of olanzapine titration schedule in patients with schizophrenia

Conditions

• Schizophrenia

Interventions

Type	Name	Description
DRUG	BR5402A	Subjects take the investigational products once a day
DRUG	BR5402A-1	Subjects take the investigational products once a day
DRUG	BR5402B	Subjects take the investigational products once a day
DRUG	BR5402B-1	Subjects take the investigational products once a day
DRUG	BR5402C	Subjects take the investigational products once a day
DRUG	BR5402C-1	Subjects take the investigational products once a day
DRUG	BR5402D	Subjects take the investigational products once a day
DRUG	BR5402D-1	Subjects take the investigational products once a day

Timeline

• Start date: 2025-05-30
• Primary completion: 2027-05-01
• Completion: 2027-05-01
• First posted: 2025-02-12
• Last updated: 2025-09-15

Locations

2 sites across 1 country: South Korea